Congo vs Madagascar: Treatment coverage for lymphatic filariasis
Congo
82.1%
in 2024
Madagascar
81.5%
in 2024
Congo rank
12th
Madagascar rank
15th
Treatment coverage for lymphatic filariasis over time
- Congo
- Madagascar
How they compare
Congo currently reports 82.1% against 81.5% in Madagascar, a difference of 0.6%.
The two have swapped places 3 times across 11 shared years of data; in 2013 it was Madagascar ahead.
Congo ranks 12th and Madagascar ranks 15th of 66 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Madagascar in 1.
Head to head by decade
| Decade | Congo | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15.9% | 33.0% | 17.1% | Madagascar |
| 2020s | 54.4% | 41.1% | 13.4% | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, Congo or Madagascar?
- Congo, at 82.1% against 81.5% in Madagascar as of 2024.
- What is the difference in treatment coverage for lymphatic filariasis between Congo and Madagascar?
- 0.6%, with Congo ahead.
- How many years of comparable data are there for Congo and Madagascar?
- 11 years are reported by both, from 2013 to 2024.
- How do Congo and Madagascar rank globally for treatment coverage for lymphatic filariasis?
- Congo ranks 12th and Madagascar ranks 15th of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.